BioCryst to buy Astria Therapeutics in $700 million deal-February 2024-www.financetom.com

BioCryst to buy Astria Therapeutics in $700 million deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025 4:39 AM

Oct 14 (Reuters) - BioCryst Pharmaceuticals ( BCRX )

said on Tuesday it would buy Astria Therapeutics ( ATXS ) in a

cash-and-stock deal valued at about $700 million, as it looks to

expand its portfolio of treatments for rare diseases.

Previous page： Host Hotels & Resorts Reports Pricing of Senior Notes due 2028 Next page： Fair Isaac Insider Sold Shares Worth $4,158,921, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Host Hotels & Resorts Reports Pricing of Senior Notes due 2028

Nov 12, 2025

05:11 PM EST, 11/12/2025 (MT Newswires) -- Host Hotels & Resorts Inc. ( HST ) said late Wednesday that Host Hotels & Resorts, L.P. has priced its $400 million offering of 4.250% senior notes due 2028. The company acts as sole general partner for Host Hotels & Resorts, L.P. Net proceeds will be used to help redeem its $400 million...

Fair Isaac Insider Sold Shares Worth $4,158,921, According to a Recent SEC Filing

Nov 12, 2025

05:11 PM EST, 11/12/2025 (MT Newswires) -- William J Lansing, Director, President and CEO, on November 10, 2025, sold 2,400 shares in Fair Isaac ( FICO ) for $4,158,921. Following the Form 4 filing with the SEC, Lansing has control over a total of 71,371 common shares of the company, with 42,138 shares held directly and 29,233 controlled indirectly. SEC...

Element Fleet Management's Q3 revenue edges past estimates, partly helped by higher utilisation rates

Nov 12, 2025

Overview * Element Q3 2025 net revenue grows 10% yr/yr, slightly beating analyst expectations * Adjusted EPS for Q3 2025 meets analyst expectations, reflecting solid operational execution * Company repurchased 4.1 mln shares under NCIB, focusing on shareholder returns Outlook * Company did not provide specific financial guidance for future periods in its press release Result Drivers * REVENUE GROWTH...

Largo Reports a Wider Third-quarter Loss, Higher Revenue

Nov 12, 2025

05:12 PM EST, 11/12/2025 (MT Newswires) -- Largo (LGO.TO) after trade on Wednesday reported a wider third-quarter loss and higher revenue. The company lost US$36.6 million, or US$0.57 per share, in the period, compared with a loss of US$10.1 million, or US$0.16, a year prior. The company said that the difference was mainly related to the non-cash derecognition of a...